Trial Profile
A phase I/II trial of irinotecan and Gimeracil/oteracil/tegafur combination therapy as a second-line treatment in patients with advanced colorectal cancer
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 30 Nov 2015
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Irinotecan (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions
- 30 Nov 2015 New trial record